In 2008, LC launched its first Global Patient Survey on Lymphomas & CLL (GPS). It has been conducted every two years since. The survey seeks to understand patient experience in lymphomas as well as the impact of treatment and care. LC and its global members use results to ensure patient voices are heard, to drive planning, actions and support.
The 2020 GPS has just concluded, and results will be posted here when they are available.
To review results from past year’s surveys, please contact the Marketing Coordinator.